Q1: 2026-04-30 Earnings Abstract
EPS of -$1.28 beats by $0.19
| Income of $16.29B (4.87% Y/Y) beats by $439.67M
Merck & Co., Inc. (MRK) Q1 2026 Earnings Name April 30, 2026 9:00 AM EDT
Firm Individuals
Peter Dannenbaum – Vice President of Investor Relations
Robert Davis – Chairman, President & CEO
Caroline Litchfield – Govt VP & CFO
Dean Li – Govt VP & President of Merck Analysis Laboratories
Convention Name Individuals
Carter Gould – Cantor Fitzgerald & Co., Analysis Division
Jason Gerberry – BofA Securities, Analysis Division
Michael Yee – UBS Funding Financial institution, Analysis Division
Asad Haider – Goldman Sachs Group, Inc., Analysis Division
Vamil Divan – Guggenheim Securities, LLC, Analysis Division
Daina Graybosch – Leerink Companions LLC, Analysis Division
Steve Scala – TD Cowen, Analysis Division
Christopher Schott – JPMorgan Chase & Co, Analysis Division
Louise Chen – Scotiabank International Banking and Markets, Analysis Division
Umer Raffat – Evercore ISI Institutional Equities, Analysis Division
James Shin – Deutsche Financial institution AG, Analysis Division
Geoffrey Meacham – Citigroup Inc., Analysis Division
Presentation
Operator
Thanks for standing by. Welcome to the Merck & Co., Inc. Rahway, New Jersey, USA, First Quarter Gross sales and Earnings Convention Name. [Operator Instructions] This name is being recorded. You probably have any objections, you could disconnect at the moment.
I’d now like to show the decision over to Mr. Peter Dannenbaum, Senior Vice President, Investor Relations. Sir, you could start.
Peter Dannenbaum
Vice President of Investor Relations
Thanks, Julie, and good morning, everybody. Welcome to the First Quarter 2026 Convention Name for Merck & Co., Inc. Rahway, New Jersey, USA. Talking on at present’s name will probably be Rob Davis, Chairman and Chief Govt Officer; Caroline Litchfield, Chief Monetary Officer; and Dr. Dean Li, President of Analysis Labs.
Earlier than we get began, I might prefer to level out that we now have objects in our GAAP outcomes equivalent to acquisition-related costs, restructuring prices and sure different objects that we now have excluded from our non-GAAP outcomes. There’s a reconciliation in our
